Armistice Capital, LLC Aquestive Therapeutics, Inc. Transaction History

Armistice Capital, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$1.29 - $2.47 $1.13 Million - $2.16 Million	-876,000 Reduced 18.25%	3,924,000 $7.93 Million
Q3 2023 Nov 14, 2023	BUY	$1.5 - $2.24 $5.46 Million - $8.16 Million	3,642,000 Added 314.51%	4,800,000 $7.34 Million
Q2 2023 Aug 14, 2023	BUY	$1.06 - $2.49 $1.23 Million - $2.88 Million	1,158,000 New	1,158,000 $1.91 Million

122

46.8M

517K

207K

Ticker AQST
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,350,700
Market Cap $200M
Description
Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual f...

Get notified when there are updates to the investment portfolio of Armistice Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Armistice Capital, LLC with notifications on news.